Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 15.74 INR
Change Today -0.14 / -0.88%
Volume 9.4K
AD On Other Exchanges
As of 6:00 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

aarey drugs & pharmaceut (AD) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/14/14 - 22.70
52 Week Low
06/4/15 - 11.27
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AAREY DRUGS & PHARMACEUT (AD)

Related News

No related news articles were found.

aarey drugs & pharmaceut (AD) Related Businessweek News

No Related Businessweek News Found

aarey drugs & pharmaceut (AD) Details

Aarey Drugs & Pharmaceuticals Limited manufactures and trades in API and bulk drug products primarily in India. Its API products include metronidazole and metronidazole benzoate; and pharmaceutical products comprise 2-methyl-5-nitroimidazole and 1-methylimidazole. The company is also developing various drugs in the therapeutic areas of anti-viral, anti-retroviral, musculoskeletal system, anti-rheumatoid, fluoroquinolones, cardiovascular, and anti-allergic segments. In addition, it imports and distributes various industrial chemicals and solvents, including methanol, toluene, xylene, acetic acid, acetone, liquor ammonia, and IPA. The company was formerly known as Niharika Textiles & Chemicals Private Limited and changed its name to Aarey Drugs & Pharmaceuticals Limited in March 1993. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

Founded in 1990

aarey drugs & pharmaceut (AD) Top Compensated Officers

Managing Director, Director, Member of Audit ...
Total Annual Compensation: 300.0K
Chief Financial Officer
Total Annual Compensation: 180.0K
Compliance Officer and Company Secretary
Total Annual Compensation: 180.0K
Compensation as of Fiscal Year 2015.

aarey drugs & pharmaceut (AD) Key Developments

Aarey Drugs & Pharmaceuticals Ltd Approves the Adoption of New Set of Articles of Association and New Set of Memorandum of Association

Aarey Drugs & Pharmaceuticals Ltd. announced that at AGM held on September 25, 2015, the shareholders of the company approved the adoption of new set of Articles of Association and adoption of new set of Memorandum of Association.

Aarey Drugs & Pharmaceuticals Ltd., Annual General Meeting, Sep 25, 2015

Aarey Drugs & Pharmaceuticals Ltd., Annual General Meeting, Sep 25, 2015.

Aarey Drugs & Pharmaceuticals Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Aarey Drugs & Pharmaceuticals Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, net income from sales/services was INR 418.495 million against INR 346.076 million last year. Operating profit before interest was INR 2.155 million against INR 8.208 million last year. Profit from ordinary activities before tax was INR 6.009 million against INR 5.784 million last year. Net profit was INR 6.009 million or INR 0.36 per basic and diluted share before extraordinary items against INR 5.784 million or INR 0.34 per basic and diluted share before extraordinary items last year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AD:IN 15.74 INR -0.14

AD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AD.
View Industry Companies

Industry Analysis


Industry Average

Valuation AD Industry Range
Price/Earnings 23.4x
Price/Sales 0.1x
Price/Book 0.7x
Price/Cash Flow 11.7x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AAREY DRUGS & PHARMACEUT, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at